A detailed history of Vestal Point Capital, LP transactions in Passage Bio, Inc. stock. As of the latest transaction made, Vestal Point Capital, LP holds 6,100,000 shares of PASG stock, worth $3.05 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
6,100,000
Previous 6,052,000 0.79%
Holding current value
$3.05 Million
Previous $4.81 Billion 11.16%
% of portfolio
0.32%
Previous 0.36%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.64 - $1.0 $30,720 - $48,000
48,000 Added 0.79%
6,100,000 $4.27 Billion
Q2 2024

Aug 14, 2024

BUY
$0.79 - $1.58 $1.23 Million - $2.45 Million
1,552,000 Added 34.49%
6,052,000 $4.81 Billion
Q1 2024

May 13, 2024

BUY
$0.86 - $1.73 $3.87 Million - $7.79 Million
4,500,000 New
4,500,000 $6.08 Billion

Others Institutions Holding PASG

About Passage BIO, Inc.


  • Ticker PASG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,463,200
  • Market Cap $27.2M
  • Description
  • Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...
More about PASG
Track This Portfolio

Track Vestal Point Capital, LP Portfolio

Follow Vestal Point Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestal Point Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Vestal Point Capital, LP with notifications on news.